R--AJCC API License

The Department of the Interior’s Interior Business Center Acquisition Services Directorate has issued a Notice of Intent to Sole Source (solicitation number DOIDFBO260015) for a firm-fixed-price license agreement with the American Joint Committee on Cancer (AJCC) for access to the AJCC Cancer Staging System via an API. This licensing arrangement is intended to support the National Cancer Institute’s Enterprise Vocabulary Services Program by integrating the standardized and authoritative AJCC cancer staging data into the NCI Thesaurus. The contract will enable harmonization and interoperability of cancer staging data critical to various NCI initiatives, as well as support the FDA and extramural research communities. The procurement is justified as sole source under FAR 13.5, recognizing AJCC as the only known provider of the required licensing and access. The planned contract term includes a one-year base period plus two one-year option periods. Submissions are sought in the form of capabilities statements by December 12, 2025, with strict requirements for electronic submission format, font size, and length limits. Proprietary or confidential information must be clearly marked and will be protected under applicable statutes. The procurement does not solicit competitive quotes or formal proposals and includes no evaluation factors or socioeconomic certifications, reflecting the non-competitive nature of the acquisition. The place of performance is at the contractor’s facilities, and delivery consists of ongoing licensed API access rather than physical goods. Inspection and acceptance will focus on compliance with AJCC’s technical standards and data accuracy to ensure seamless integration into NCI systems. Key administrative details such as payment office, invoicing instructions, and specific appropriation data are not provided. The sole point of contact for correspondence is the contracting officer at the Interior Business Center. Overall, this acquisition aims to secure exclusive licensing rights critical to cancer research standardization, executed under a streamlined, sole-source contracting approach.